Phase II trial of sunitinib malate in patients with temozolomide refractory recurrent high-grade glioma

被引：0
|
作者：
Neyns, B. [1 ,2 ]
Chaskis, C. [1 ,2 ]
Dujardin, M. [1 ,2 ]
Everaert, H. [1 ,2 ]
Sadones, J. [1 ,2 ]
Nupponen, N. N. [1 ,2 ]
Michotte, A. [1 ,2 ]
机构：
[1] UZ Brussel, Brussels, Belgium
[2] Univ Helsinki, Helsinki, Finland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2038
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Temozolomide versus Procarbazine, Lomustine, and Vincristine in Recurrent High-grade Glioma
    Nieder, Carsten
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (05) : 333 - 335
  • [42] Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
    Brada, Michael
    Stenning, Sally
    Gabe, Rhian
    Thompson, Lindsay C.
    Levy, David
    Rampling, Roy
    Erridge, Sara
    Saran, Frank
    Gattamaneni, Rao
    Hopkins, Kirsten
    Beall, Sarah
    Collins, V. Peter
    Lee, Siow-Ming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) : 4601 - 4608
  • [43] Phase II trial of combination pembrolizumab, olaparib, and temozolomide for patients with recurrent glioma
    Schaff, Lauren
    Fortunato, John
    Grommes, Christian
    Gavrilovic, Igor T.
    Lin, Andrew
    Pentsova, Elena
    Miller, Alex
    Newton, Adam
    Gonzalez, Ashley
    Mellinghoff, Ingo K.
    Kaley, Thomas Joseph
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] RESULTS OF A PHASE IIB STUDY WITH TRABEDERSEN (AP 12009) IN RECURRENT OR REFRACTORY HIGH-GRADE GLIOMA PATIENTS
    Bogdahn, Ulrich
    Rappaport, Z. H.
    Olyusin, V.
    Parfenov, V.
    Mahapatra, A. K.
    Balasubramaniam, A.
    Vankataramana, N. K.
    Stockhammer, G.
    Heinrichs, H.
    Schlingensiepen, K. -H.
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 907 - 908
  • [45] Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma
    Han, Seunggu J.
    Rolston, John D.
    Molinaro, Annette M.
    Clarke, Jennifer L.
    Prados, Michael D.
    Chang, Susan M.
    Berger, Mitchel S.
    DeSilva, Ashley
    Butowski, Nicholas A.
    [J]. NEURO-ONCOLOGY, 2014, 16 (09) : 1255 - 1262
  • [46] A MULTICENTER STRATIFIED PHASE II STUDY OF CETUXIMAB FOR THE TREATMENT OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA
    Neyns, B.
    Sadones, J.
    Joosens, E.
    Bouttens, F.
    Verbeke, L.
    Baurain, J.
    Dhondt, L.
    Strauven, T.
    Chaskis, C.
    Michotte, A.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1067 - 1067
  • [47] A multicenter stratified phase II study of cetuximab for the treatment of patients with recurrent high-grade glioma
    Neyns, B.
    Sadones, J.
    Joosens, E.
    Bouttens, F.
    Verbeke, L.
    Baurain, J. F.
    D'Hondt, L.
    Chaskis, C.
    Michotte, A.
    De Greve, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] Phase I study of terameprocol in patients with recurrent high-grade glioma
    Grossman, Stuart A.
    Ye, Xiaobu
    Peereboom, David
    Rosenfeld, Myrna R.
    Mikkelsen, Tom
    Supko, Jeffrey G.
    Desideri, Serena
    [J]. NEURO-ONCOLOGY, 2012, 14 (04) : 511 - 517
  • [49] Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021
    Wetmore, Cynthia
    Daryani, Vinay M.
    Billups, Catherine A.
    Boyett, James M.
    Leary, Sarah
    Tanos, Rachel
    Goldsmith, Kelly C.
    Stewart, Clinton F.
    Blaney, Susan M.
    Gajjar, Amar
    [J]. CANCER MEDICINE, 2016, 5 (07): : 1416 - 1424
  • [50] PHASE II TRIAL OF DOSE-DENSE 1 WEEK ON/1 WEEK OFF TEMOZOLOMIDE FOR PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
    Han, Seunggu
    Molinaro, Annette
    Berger, Mitchel
    Prados, Michael
    Chang, Susan
    Clarke, Jennifer
    Butowski, Nicholas
    [J]. NEURO-ONCOLOGY, 2013, 15 : 111 - 111
12345